Avita Medical Statistics
Avita Medical (51KA) Stock Statistics & Valuation Metrics
Total Valuation
Avita Medical has a market cap or net worth of EUR 496.53M. The enterprise value is EUR 398.69M.
- Market Cap
- EUR 496.53M
- Enterprise Value
- EUR 398.69M
Share Statistics
Avita Medical has 31,420,220 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 31,420,220
- Owned by Insiders
- 2.42%
- Owned by Institutions
- 10.81%
Financial Efficiency
Avita Medical’s return on equity (ROE) is 2.92 and return on invested capital (ROIC) is -113.04%.
- Return on Equity (ROE)
- 2.92
- Return on Assets (ROA)
- -0.86
- Return on Invested Capital (ROIC)
- -113.04%
- Return on Capital Employed (ROCE)
- 6.77
- Revenue Per Employee
- 316.86K
- Profits Per Employee
- -214.99K
- Employee Count
- 226
- Asset Turnover
- 1.27
- Inventory Turnover
- 1.85
Valuation Ratios
The current PE Ratio of Avita Medical is -14.54. Avita Medical’s PEG ratio is -0.33.
- PE Ratio
- -14.54
- PS Ratio
- 5.08
- PB Ratio
- -17.20
- Price to FCF
- -23.56
- Price to Operating Cash Flow
- -27.08
- PEG Ratio
- -0.33
Income Statement
In the last 12 months, Avita Medical had revenue of 71.61M and earned -48.59M in profits. Earnings per share was -1.74.
- Revenue
- 71.61M
- Gross Profit
- 58.82M
- Operating Income
- -42.53M
- Pretax Income
- -48.58M
- Net Income
- -48.59M
- EBITDA
- -41.23M
- Earnings Per Share (EPS)
- -1.74
Cash Flow
In the last 12 months, operating cash flow was -19.72M and capital expenditures 1.48M, giving a free cash flow of -18.24M billion.
- Operating Cash Flow
- -19.72M
- Free Cash Flow
- -18.24M
- Free Cash Flow per Share
- -0.59
Dividends & Yields
Avita Medical pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -4.24%
- Earnings Yield
- -6.76%
Stock Price Statistics
- Beta
- 1.34
- 52-Week Price Change
- 341.52%
- 50-Day Moving Average
- 11.15
- 200-Day Moving Average
- 5.88
- Relative Strength Index (RSI)
- 64.76
- Average Volume (3m)
- 944
Important Dates
Avita Medical upcoming earnings date is Feb 25, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 05, 2026
- Next Earnings Date
- Feb 25, 2027
- Ex-Dividend Date
- ―
Financial Position
Avita Medical as a current ratio of 0.57, with Debt / Equity ratio of -276.56%
- Current Ratio
- 0.57
- Quick Ratio
- 0.46
- Debt to Market Cap
- 0.45
- Net Debt to EBITDA
- -0.87
- Interest Coverage Ratio
- -8.50
Taxes
In the past 12 months, Avita Medical has paid 11.00K in taxes.
- Income Tax
- 11.00K
- Effective Tax Rate
- -0.00
Enterprise Valuation
Avita Medical EV to EBITDA ratio is -16.35, with an EV/FCF ratio of -25.57.
- EV to Sales
- 5.51
- EV to EBITDA
- -16.35
- EV to Free Cash Flow
- -25.57
- EV to Operating Cash Flow
- -23.66
Balance Sheet
Avita Medical has EUR 10.50M in cash and marketable securities with EUR 47.13M in debt, giving a net cash position of -EUR 36.63M billion.
- Cash & Marketable Securities
- EUR 10.50M
- Total Debt
- EUR 47.13M
- Net Cash
- -EUR 36.63M
- Net Cash Per Share
- -EUR 1.17
- Tangible Book Value Per Share
- -EUR 1.19
Margins
Gross margin is 82.36%, with operating margin of -33.89%, and net profit margin of -42.65%.
- Gross Margin
- 82.36%
- Operating Margin
- -33.89%
- Pretax Margin
- -42.57%
- Net Profit Margin
- -42.65%
- EBITDA Margin
- -33.68%
- EBIT Margin
- -35.96%
Analyst Forecast
The average price target for Avita Medical is EUR 16.35, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- EUR 16.35
- Price Target Upside
- 8.31% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 3
- Revenue Growth Forecast
- 11.04%
- EPS Growth Forecast
- 38.35%
Scores
- Smart Score
- 10
- AI Score
- ―
